SE‑Cluster

Search

Search markets, companies, evidence, and pages

TickerTEM
SectorMedical - Healthcare Information Services
Mkt cap$8.7B
EV / EBITDAN/A
PostureHigh Velocity
Composite64/100
LensTarget-side
SE-Cluster Research·Issuer Brief·Q2 2026CIK 1717115

Tempus AI, Inc.

TEMHIGH VELOCITYFILING INTENSITY

Tempus AI, Inc. reads as High Velocity (composite 64/100); pressure / disclosure signals dominate the posture this cycle · primary market Marketing & Data.

Lens

Disclosed M&A capital (2023–2025)

$396M

new

vs N/A in 2020–2022

Disclosed transactions

5

new

2/3 active fiscal years in window

Buyer archetype

Selective Buyer

Acquisition use is visible but targeted.

Composite score

64

/100

High Velocity dominates · Filing Intensity

Financial snapshot
Revenue$1.4B
EBITDAN/A
Enterprise value$9B
EV / Revenue6.6×
EV / EBITDAN/A
P/EN/A
Cash$521M
Total debtN/A
as of 2026-05-10
§ I·SE-Cluster Issuer Brief

Behavioral posture, nine reads.

Each index scores the issuer 0–100 against an EDGAR-anchored definition. Scores ≥ threshold elevate the issuer into the index's constituent set; the dominant index drives the masthead label.

Active Acquirer

25/100

Companies actively deploying disclosed capital into M&A

  • $396M disclosed buyer spend

Buyer Cadence

16/100

Buyer-side companies with recent filing activity

  • Filed within 35d
  • 19 8-Ks

Target Probability

12/100

Issuers showing target-side patterns from filings

  • 2 activism filings

Spin/Carve

0/100

Issuers showing spin-off, carve-out, or sum-of-parts posture

  • 2 activism filings

Pressure Watch

28/100

Issuers facing activism, governance, or control pressure

  • 2 activism filings
  • Latest activism 1.8y ago

Distress Watch

9/100

Issuers showing financial-distress filing patterns

  • 2 activism filings

Restatement Risk

0/100

Issuers with accounting-integrity flags from filings

Capital Velocity

Dominant
64/100

Issuers with the highest filing-activity intensity

  • 19 8-Ks
  • 5 form types

Quiet Power

0/100

Large issuers with low signal volume and clean disclosure cadence

  • Enterprise value $9B
  • 10-Q 35d ago
  • 2 active signals
§ II·SE-Cluster Issuer Brief

Capital cadence.

Ten-year disclosed M&A activity. Bars show spend ($MM); ticks show recorded transaction count. Disclosure tier annotated where v6 audited corpus carries an entry.

16
17
18
19
20
21
22
23
24
25

Disclosed spend $MM Disclosed transactions (right axis)Peak spend year: $377M · Peak count: 3

FYDisclosed buysDisclosed spendAvg ticketAudited tier
20253$377M$126MN/A
20242$20M$10MN/A
2023N/AN/AN/AN/A
2022N/AN/AN/AN/A
2021N/AN/AN/AN/A
2020N/AN/AN/AN/A
§ III·SE-Cluster Issuer Brief

Strategy posture.

The buyer's playbook in terms of strategic archetype: what each disclosed move says about how they're deploying capital.

Archetype mix

  • Technology Acquisition
    25%
  • Bolt On
    25%
  • Vertical Integration
    25%
  • Horizontal Consolidation
    25%

Strategy keywords

Terms recurring across recent 10-K acquisition disclosures.

  • technology_acquisition
  • bolt_on
  • vertical_integration
  • horizontal_consolidation
§ IV·SE-Cluster Issuer Brief

Filing language.

Direct excerpts from acquisition disclosures and strategy sections: the verbs the buyer chose, in the filings they signed.

The Paige Acquisition is expected to allow the Company to grow its dataset and establish a strong footprint in digital pathology with an industry leading technology portfolio.

10-KFY2025

Ambry Acquisition complements the Company's strategy of using data to advance clinical and scientific innovation.

10-KFY2025
§ V·SE-Cluster Issuer Brief

Market context.

Where this issuer sits inside its SE-Cluster rollup wedge, with disclosed-spend rank plus trading comparables against the public peer set.

Primary market

Marketing & Data

Market spend (2023–2025)
$51.4B
Market spend (2020–2022)
$63.5B
Recent vs prior
−19%
Issuer rank in market
N/A
Share of market capital
0.0%

Valuation positioning

Trading comparables unavailable for this wedge.

§ VI·SE-Cluster Issuer Brief

Buyer landscape.

Public buyers whose stated archetypes, target categories, and recent cadence align with this issuer as a plausible acquisition target. Scores cross EDGAR signal and disclosure overlap.

Likely buyers

No public buyers surface as a strong target-side fit on current signal.

Likely sellers / divestiture partners

No reciprocal divestiture / strategic-alternatives matches identified.

§ VII·SE-Cluster Issuer Brief

Filing activity & signal stream.

Filing cadence and event-driven signals visible on EDGAR. The signal stream below is curated from restatement / spin-carve / activism categories, providing context for any near-term call.

Filing cadence

  • 10-K (annual)22026-02-24
  • 10-Q (quarterly)62026-05-05
  • 8-K (event)192026-05-05
  • Proxy / DEF 14A42026-04-07
  • Activism (13D / DFAN / PREC)22024-08-20

Signals on file

  • elevated

    Activism on file

    2024-08-20

    2 activist filings on file (13D, DFAN14A, PREC14A series).

  • info

    Signal

    Serial acquisition history

  • info

    Signal

    10-K strategy themes

§ VIII·SE-Cluster Issuer Brief

Audited corpus.

No audited record on file for this CIK in the current v6 corpus.

This issuer has not been extracted into the v6 audited acquirer corpus yet. The brief above pulls from ranking-level aggregates and issuer-index signal only.